Hwail Pharmaceutical, Anthelmintic Drugs (Fenbendazole, etc.) Theme Rises 8.18% Up
On the 2nd, the anthelmintic (including Fenbendazole) theme rose 4.44% compared to the previous day, showing strength, while Hwail Pharmaceuticals, which is attracting attention as a related stock, surged 8.18% compared to the previous day. Hwail Pharmaceuticals is known as a specialized manufacturer of pharmaceutical raw materials.
[Graph] Major stock price changes in the anthelmintic (including Fenbendazole) theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Hwail Pharmaceuticals ranked 2nd out of 7 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Hwail Pharmaceuticals having relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.
[Table] Top stocks by financial score within the theme
※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military Spokesperson: "Ceasefire Was an Opportunity to Strengthen Forces... Ready to Respond to War"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.